Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edit functionality is currently unavailable.

Sara Ahmadi, M.D.

Title
Institution
Department
Address
Phone
Profile Picture

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Jug R, Foo WC, Jones C, Ahmadi S, Jiang XS. High-risk and intermediate-high-risk results from the ThyroSeq v2 and v3 thyroid genomic classifier are associated with neoplasia: Independent performance assessment at an academic institution. Cancer Cytopathol. 2020 Aug; 128(8):563-569. PMID: 32339438.
    Citations:    
  2. Ahmadi S, Gonzalez JM, Talbott M, Reed SD, Yang JC, Scheri RP, Stang M, Roman S, Sosa JA. Patient Preferences Around Extent of Surgery in Low-Risk Thyroid Cancer: A Discrete Choice Experiment. Thyroid. 2020 07; 30(7):1044-1052. PMID: 32143553.
    Citations:    
  3. Guan H, de Morais NS, Stuart J, Ahmadi S, Marqusee E, Kim MI, Alexander EK. Discordance of serological and sonographic markers for Hashimoto's thyroiditis with gold standard histopathology. Eur J Endocrinol. 2019 Nov; 181(5):539-544. PMID: 31536967.
    Citations:    
  4. Ahmadi S, Roman SA, Sosa JA. RE: RE: A DIRECT COMPARISON OF THE ATA AND TI-RADS ULTRASOUND SCORING SYSTEMS. Endocr Pract. 2019 09; 25(9):975. PMID: 31509465.
    Citations:    
  5. Parajuli S, Jug R, Ahmadi S, Jiang XS. Hurthle cell predominance impacts results of Afirma gene expression classifier and ThyroSeq molecular panel performance in indeterminate thyroid nodules. Diagn Cytopathol. 2019 Nov; 47(11):1177-1183. PMID: 31348619.
    Citations:    
  6. Ahmadi S, Herbst R, Oyekunle T, Jiang X', Strickland K, Roman S, Sosa JA. USING THE ATA AND ACR TI-RADS SONOGRAPHIC CLASSIFICATIONS AS ADJUNCTIVE PREDICTORS OF MALIGNANCY FOR INDETERMINATE THYROID NODULES. Endocr Pract. 2019 Sep; 25(9):908-917. PMID: 31170369.
    Citations:    
  7. Jug R, Parajuli S, Ahmadi S, Jiang XS. Negative Results on Thyroid Molecular Testing Decrease Rates of Surgery for Indeterminate Thyroid Nodules. Endocr Pathol. 2019 Jun; 30(2):134-137. PMID: 30825100.
    Citations:    
  8. Bethel MA, Patel RA, Thompson VP, Merrill P, Reed SD, Li Y, Ahmadi S, Katona BG, Gustavson SM, Ohman P, Iqbal N, Gagel RF, Hernandez AF, Buse JB, Holman RR. Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL). Diabetes Care. 2019 06; 42(6):1075-1080. PMID: 31010875.
    Citations:    
  9. Ahmadi S, Oyekunle T, Jiang X', Scheri R, Perkins J, Stang M, Roman S, Sosa JA. A DIRECT COMPARISON OF THE ATA AND TI-RADS ULTRASOUND SCORING SYSTEMS. Endocr Pract. 2019 May; 25(5):413-422. PMID: 30720343.
    Citations:    
  10. Cox C, Bosley M, Southerland LB, Ahmadi S, Perkins J, Roman S, Sosa JA, Carneiro-Pla D. Lobectomy for treatment of differentiated thyroid cancer: can patients avoid postoperative thyroid hormone supplementation and be compliant with the American Thyroid Association guidelines? Surgery. 2018 01; 163(1):75-80. PMID: 29122328.
    Citations:    
  11. Ahmadi S, Rojas CR, Policarpio-Nicolas ML, Metter D, Avery D, Prihoda TJ, Sabra MM. VARIABILITY IN THYROID CANCER MANAGEMENT AND PROGNOSIS AMONG HISPANIC VERSUS NON-HISPANIC PATIENTS : 17 YEARS DATA FROM UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AND UNIVERSITY HEALTH SYSTEM AT SAN ANTONIO. Endocr Pract. 2017 Aug 17. PMID: 28816541.
    Citations:    
  12. Ahmadi S, Stang M, Jiang XS, Sosa JA. Hürthle cell carcinoma: current perspectives. Onco Targets Ther. 2016; 9:6873-6884. PMID: 27853381.
    Citations:    
  13. Ahmadi S, Alvi S, Urban RJ. Nonclassic congenital adrenal hyperplasia and the heterozygote carrier. Expert Rev Endocrinol Metab. 2013 May; 8(3):239-246. PMID: 30780815.
    Citations:    
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Ahmadi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (44)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.